المؤلفون: Yoshinobu Saito, Masafumi Sata, Yoshihiko Ito, Takahiko Sakamoto, Yuichiro Ohe, Noriyo Yanagawa, Masahiko Kusumoto, Shinichi Sasaki, Tomohisa Baba, Tae Iwasawa, Kazuyoshi Kuwano, Hiroaki Sugiura, Yutaka Fujiwara, Masahiro Endo, Terufumi Kato, Junya Tominaga, Fumikazu Sakai, Katsunori Oikado, Hirotsugu Kenmotsu

المصدر: Cancer Science

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Pleural effusion, non‐small‐cell lung carcinoma, Gastroenterology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Japan, Clinical Research, Risk Factors, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Carcinoma, interstitial lung diseases, Humans, Diffuse alveolar damage, Lung cancer, Lung, Aged, Retrospective Studies, nivolumab, computed X‐ray tomography, business.industry, Hazard ratio, Interstitial lung disease, prognostic factors, General Medicine, Middle Aged, respiratory system, Prognosis, medicine.disease, respiratory tract diseases, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Original Article, Female, ORIGINAL ARTICLES, Nivolumab, Lung Diseases, Interstitial, business, Cryptogenic Organizing Pneumonia

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c7e084a34fe1233978dafbf1da993ffTest
https://doi.org/10.1111/cas.14710Test

المؤلفون: Yuichiro Ohe, Masafumi Sata, Kazuyoshi Kuwano, Yoshinobu Saito, Tomohisa Baba, Masahiko Kusumoto, Tae Iwasawa, Yoshihiko Ito, Takahiko Sakamoto, Yutaka Fujiwara, Terufumi Kato, Noriyo Yanagawa, Shinichi Sasaki, Junya Tominaga, Hirotsugu Kenmotsu, Masahiro Endo, Katsunori Oikado, Fumikazu Sakai, Hiroaki Sugiura

المصدر: Cancer Science

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, medicine.medical_treatment, Interstitial lung disease, Adverse drug events, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Japan, Clinical Research, Internal medicine, Carcinoma, Non-Small-Cell Lung, Carcinoma, Medicine, Humans, Lung cancer, Adverse effect, Aged, Retrospective Studies, business.industry, Antibodies, Monoclonal, Retrospective cohort study, General Medicine, Immunotherapy, respiratory system, Middle Aged, medicine.disease, Non‐small‐cell lung carcinoma, respiratory tract diseases, 030104 developmental biology, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Corticosteroid, Original Article, Female, ORIGINAL ARTICLES, Neoplasm Recurrence, Local, business, Lung Diseases, Interstitial

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a45209a9c966db7d6ee4d6d12506a8dTest
http://europepmc.org/articles/PMC8019226Test

المؤلفون: Yoshinobu Saito, Masahiko Kusumoto, Yuichiro Ohe, Masafumi Sata, Kei Sakamoto, Terufumi Kato, Toshimitsu Tokimoto, Reiko Tamura, Tomohisa Baba, Akihiko Gemma, Masatoshi Sugeno, Ou Yamaguchi, Wataru Shimizu, Masahiro Endo, Fumikazu Sakai

المصدر: Japanese Journal of Clinical Oncology

مصطلحات موضوعية: 0301 basic medicine, safety, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Population, QT interval, Gastroenterology, Liver disorder, 03 medical and health sciences, 0302 clinical medicine, Japan, Internal medicine, Carcinoma, Non-Small-Cell Lung, Medicine, AcademicSubjects/MED00300, Humans, Radiology, Nuclear Medicine and imaging, Osimertinib, Lung cancer, education, Adverse effect, Protein Kinase Inhibitors, non-small cell lung cancer, Aged, education.field_of_study, Acrylamides, Aniline Compounds, business.industry, Interstitial lung disease, General Medicine, medicine.disease, Confidence interval, Progression-Free Survival, ErbB Receptors, Survival Rate, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, osimertinib, Mutation, Original Article, Female, business, epidermal growth factor receptor

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b4556abdbca0ecb767d113e698aa22Test
http://europepmc.org/articles/PMC7401719Test

المؤلفون: Takashi Kasai, Ryo Arai, Masahiko Okada, Ayako Takigami, Ichiro Nakachi, Takayuki Kishikawa, Masafumi Sata, Sayo Soda

المصدر: Thoracic Cancer, Vol 11, Iss 4, Pp 935-942 (2020)
Thoracic Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Lung Neoplasms, Tyrosine-kinase inhibitor, T790M, tyrosine kinase inhibitor, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Osimertinib, Aged, 80 and over, Aniline Compounds, General Medicine, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, ErbB Receptors, Survival Rate, osimertinib, 030220 oncology & carcinogenesis, Female, Original Article, Adult, non‐small cell lung cancer, Pulmonary and Respiratory Medicine, medicine.medical_specialty, medicine.drug_class, Adenocarcinoma of Lung, Neutropenia, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, medicine, Humans, Adverse effect, Protein Kinase Inhibitors, Aged, Retrospective Studies, Pneumonitis, Acrylamides, Proportional hazards model, business.industry, Original Articles, medicine.disease, respiratory tract diseases, Epidermal growth factor receptor T790M mutation, 030104 developmental biology, Carcinoma, Large Cell, Recurrent Non-Small Cell Lung Carcinoma, Neoplasm Recurrence, Local, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd21b221710ea3d5f464c5dcc42b683dTest
https://doi.org/10.1111/1759-7714.13378Test

المؤلفون: Masahiro Endo, Hirotsugu Kenmotsu, Yoshinobu Saito, Noriyo Yanagawa, Takashi Koshiba, Shinichi Sasaki, Naoya Yamazaki, Fumikazu Sakai, Hiroaki Sugiura, Masafumi Sata, Tae Iwasawa, Yuichiro Ohe, Masahiko Kusumoto, Katsunori Oikado, Junya Tominaga, Terufumi Kato, Yutaka Fujiwara, Kazuyoshi Kuwano, Takahiko Sakamoto, Tomohisa Baba

المصدر: Future Oncology. 15:1911-1920

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Programmed Cell Death 1 Receptor, Postmarketing surveillance, Severity of Illness Index, Ground-glass opacity, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Humans, Medicine, Lung cancer, Melanoma, Aged, Pneumonitis, Aged, 80 and over, business.industry, Interstitial lung disease, Pneumonia, General Medicine, Middle Aged, medicine.disease, Radiography, Nivolumab, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Radiological weapon, Female, Radiology, medicine.symptom, Tomography, X-Ray Computed, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925019da69eb257dba887360e460d06eTest
https://doi.org/10.2217/fon-2019-0102Test

المؤلفون: Kazushige Wakuda, Satoshi Ikeda, Masafumi Sata, Ryota Ushio, Kentaro Ito, Takashi Sato, Shigeru Tanzawa, Naoki Furuya, Makoto Nishino

المصدر: Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 5, Pp 613-618 (2021)

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Adult, Male, atezolizumab, non‐small cell lung cancer, medicine.medical_specialty, Lung Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Cohort Studies, 03 medical and health sciences, anti‐PD‐L1, 0302 clinical medicine, Atezolizumab, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Lung cancer, Immune Checkpoint Inhibitors, Aged, Retrospective Studies, Aged, 80 and over, Performance status, business.industry, Anti pd 1, General Medicine, Original Articles, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Confidence interval, 030104 developmental biology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Retreatment, Female, Original Article, Nivolumab, business, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12194075aa42c60389387090977b3ce3Test
https://pubmed.ncbi.nlm.nih.gov/33448648Test